Disclosures for "Retinal Ganglion Cell Loss Thresholds Predict Multimodal Visual Dysfunction Following Demyelinating Optic Neuritis"
-
Dr. Subhi has nothing to disclose.
-
Mr. Manukyan has nothing to disclose.
-
Miss Zabala has nothing to disclose.
-
Ms. Locke has nothing to disclose.
-
Dr. Guerrero has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
-
Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Eichhorn & Eichhorn, LLP. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Venable LLC. The institution of Dr. Kaisey has received research support from NMSS. The institution of Dr. Kaisey has received research support from Race to Erase MS.
-
Dr. Khodabakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch and Lomb. Dr. Khodabakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Khodabakhsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bausch and Lomb. Dr. Khodabakhsh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bausch and Lomb.
-
Aaron Carass has nothing to disclose.
-
Jerry Prince has stock in Sonavex. The institution of Jerry Prince has received research support from PCORI. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from CDMRP. The institution of Jerry Prince has received research support from National MS Society. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from NSF. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from NIH. The institution of Jerry Prince has received research support from Genentech. The institution of Jerry Prince has received research support from NIH. Jerry Prince has received intellectual property interests from a discovery or technology relating to health care. Jerry Prince has received intellectual property interests from a discovery or technology relating to health care. Jerry Prince has received intellectual property interests from a discovery or technology relating to health care. Jerry Prince has received publishing royalties from a publication relating to health care.
-
Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
-
Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
-
The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
-
The institution of Dr. Sati has received research support from National Multiple Sclerosis Society. The institution of Dr. Sati has received research support from National Institutes of Health. Dr. Sati has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Dr. Al-Louzi has received research support from the National Multiple Sclerosis Society and American Brain Foundation. The institution of Dr. Al-Louzi has received research support from the Department of Defense.